OPKO Health (NASDAQ:OPK) Given Outperform Rating at Barrington Research
OPKO Health (NASDAQ:OPK – Get Free Report)‘s stock had its “outperform” rating reissued by equities researchers at Barrington Research in a report released on Wednesday,Benzinga reports. They currently have a $2.25 price objective on the biotechnology company’s stock. Barrington Research’s price objective would indicate a potential upside of 30.81% from the stock’s previous close. Several […]
OPKO Health (NASDAQ:OPK – Get Free Report)‘s stock had its “outperform” rating reissued by equities researchers at Barrington Research in a report released on Wednesday,Benzinga reports. They currently have a $2.25 price objective on the biotechnology company’s stock. Barrington Research’s price objective would indicate a potential upside of 30.81% from the stock’s previous close. Several […]
